Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry.
Gabiña PM, Gleisner KS, Cremonesi M, Stokke C, Flux G, Cicone F, Konijnenberg M, Aldridge M, Sandstrom M, Chiesa C, Paphiti M, Hippeläinen E, Uribe C, Solny P, Gnesin S, Bernhardt P, Chouin N, Costa PF, Glatting G, Verburg F, Gear J. Gabiña PM, et al. Among authors: gleisner ks. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2595-2604. doi: 10.1007/s00259-023-06215-2. Eur J Nucl Med Mol Imaging. 2023. PMID: 37129712 No abstract available.
Dosimetry-based treatment planning for molecular radiotherapy: a summary of the 2017 report from the Internal Dosimetry Task Force.
Stokke C, Gabiña PM, Solný P, Cicone F, Sandström M, Gleisner KS, Chiesa C, Spezi E, Paphiti M, Konijnenberg M, Aldridge M, Tipping J, Wissmeyer M, Brans B, Bacher K, Kobe C, Flux G. Stokke C, et al. Among authors: gleisner ks. EJNMMI Phys. 2017 Nov 21;4(1):27. doi: 10.1186/s40658-017-0194-3. EJNMMI Phys. 2017. PMID: 29164483 Free PMC article.
Bone Marrow Absorbed Doses and Correlations with Hematologic Response During 177Lu-DOTATATE Treatments Are Influenced by Image-Based Dosimetry Method and Presence of Skeletal Metastases.
Hagmarker L, Svensson J, Rydén T, van Essen M, Sundlöv A, Gleisner KS, Gjertsson P, Bernhardt P. Hagmarker L, et al. Among authors: gleisner ks. J Nucl Med. 2019 Oct;60(10):1406-1413. doi: 10.2967/jnumed.118.225235. Epub 2019 Mar 22. J Nucl Med. 2019. PMID: 30902877 Free PMC article.
Re: Tumor Targeting and Three-Dimensional Voxel-Based Dosimetry to Predict Tumor Response, Toxicity, and Survival after Yttrium-90 Resin Microsphere Radioembolization in Hepatocellular Carcinoma.
Walrand S, Chiesa C, Gabina PM, Chouin N, Gear J, Stokke C, Bernhardt P, Gleisner KS, Strigari L, Konijnenberg M; EANM Dosimetry Committee. Walrand S, et al. Among authors: gleisner ks. J Vasc Interv Radiol. 2019 Dec;30(12):2047-2048. doi: 10.1016/j.jvir.2019.08.030. Epub 2019 Oct 30. J Vasc Interv Radiol. 2019. PMID: 31676203 No abstract available.
Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients.
Sundlöv A, Gleisner KS, Tennvall J, Ljungberg M, Warfvinge CF, Holgersson K, Hallqvist A, Bernhardt P, Svensson J. Sundlöv A, et al. Among authors: gleisner ks. Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3830-3840. doi: 10.1007/s00259-022-05786-w. Epub 2022 Apr 22. Eur J Nucl Med Mol Imaging. 2022. PMID: 35451612 Free PMC article. Clinical Trial.
27 results